对COPD的皮质类固醇和抗生素的时间更新的表型指导:理由,视角和拟议的方法
Alexander Jordan1, Pradeesh Sivapalan1, Valdemar Rømer1
1Section of Respiratory Medicine, Herlev-Gentofte University Hospital, 2900 Hellerup, Denmark.
Biomedicines
|May 27, 2023
概括
监测血液中乙氨基酸和前素水平可以指导慢性阻塞性肺病 (COPD) 恶化的治疗,安全地减少皮质类固醇和抗生素的使用,同时改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,患者表型不同,需要量身定制的治疗方法.
- 可通过血液中乙酸细胞计数识别的乙酸性气道炎症是导致COPD患者子组恶化的一个关键表型.
- 目前COPD恶化的治疗策略通常涉及皮质类固醇和抗生素,带有副作用和耐药性的风险.
研究的目的:
- 评估以乙氨基基基导疗法在减少COPD恶化的皮质类固醇暴露方面的疗效.
- 评估前素在指导COPD急性恶化的抗生素治疗中的作用 (AECOPD).
- 确定生物标志物引导的治疗策略是否可以在COPD管理中安全地减少药物暴露.
主要方法:
- 每天监测血液中乙氨基细胞的数量,以指导在急性恶化中使用口服皮质类固醇.
- 利用前素水平来为住院AECOPD患者的抗生素处方决定提供信息.
- 分析使用时间独立和时间更新算法进行生物标记指导干预的研究数据.
主要成果:
- 每天对乙氨基酸细胞进行监测,有效地减少了口服皮质类固醇的暴露和急性COPD恶化中相关的副作用.
- 在AECOPD中以前素为导向的抗生素治疗成功地减少了抗生素暴露,而不会对死亡率或停留时间产生负面影响.
- 研究表明,在时间独立和时间更新的方法中,通过甲指导显著减少了抗生素暴露.
结论:
- 以生物标志物为指导的管理,特别是使用血液中的乙氨基和前素,提供了一种安全有效的方法来个性化治疗COPD.
- 这些策略显著减少了对皮质类固醇和抗生素的不必要暴露,减轻了相关风险,并促进了抗菌药物管理.
- 进一步的研究正在进行中,以探索在稳定的COPD中使用eosinophil引导的吸入性皮质类固醇,突出显示在呼吸护理中精密医学的不断变化的景观.
关键词:
慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.慢性慢性肺炎的急性恶化生物标志物 生物标志物皮质类固醇是什么埃索诺菲尔细胞的存在吸入性皮质类固醇的使用.这是什么意思? procalcitonin.呼吸道感染 呼吸道感染更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
319
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
319
01:17Drugs Used in Lower Respiratory Disorders: Overview
509
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
509
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20COPD: Pathogenesis and Clinical Features
371
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
371